![Cureus | Evaluating the Utility of Prostate-Specific Antigen Density in Risk Stratification of PI-RADS 3 Peripheral Zone Lesions on Non-Contrast-Enhanced Prostate MRI: An Exploratory Single-Institution Study | Article Cureus | Evaluating the Utility of Prostate-Specific Antigen Density in Risk Stratification of PI-RADS 3 Peripheral Zone Lesions on Non-Contrast-Enhanced Prostate MRI: An Exploratory Single-Institution Study | Article](https://assets.cureus.com/uploads/figure/file/664744/article_river_2883dba00e1b11eeabf04fb5ec444df9-Figure-1-ver-2.png)
Cureus | Evaluating the Utility of Prostate-Specific Antigen Density in Risk Stratification of PI-RADS 3 Peripheral Zone Lesions on Non-Contrast-Enhanced Prostate MRI: An Exploratory Single-Institution Study | Article
![Sub-differentiating equivocal PI-RADS-3 lesions in multiparametric magnetic resonance imaging of the prostate to improve cancer detection - ScienceDirect Sub-differentiating equivocal PI-RADS-3 lesions in multiparametric magnetic resonance imaging of the prostate to improve cancer detection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0720048X17303364-gr1.jpg)
Sub-differentiating equivocal PI-RADS-3 lesions in multiparametric magnetic resonance imaging of the prostate to improve cancer detection - ScienceDirect
![Review of Clinically Significant Cancer in Lesions Labeled PI-RADS 3 on MRI Using PI- RADS Version 2.1 • APPLIED RADIOLOGY Review of Clinically Significant Cancer in Lesions Labeled PI-RADS 3 on MRI Using PI- RADS Version 2.1 • APPLIED RADIOLOGY](https://cdn.agilitycms.com/applied-radiology/MediaGroupings/6794/SateiLOH_figure01b.jpg)
Review of Clinically Significant Cancer in Lesions Labeled PI-RADS 3 on MRI Using PI- RADS Version 2.1 • APPLIED RADIOLOGY
![Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI- RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI- RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment](https://www.eu-focus.europeanurology.com/cms/asset/cc159e92-f753-4a78-9f8b-cb8c4703bc64/gr1.jpg)
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI- RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment
![MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology](https://cdn.amegroups.cn/journals/amepc/files/journals/3/articles/18050/public/18050-PB8-R1.png/w300)
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
![Systematic Biopsy of the Prostate Can Be Omitted in Men With PI-RADS™ 5 and PSA Density >15 | PracticeUpdate Systematic Biopsy of the Prostate Can Be Omitted in Men With PI-RADS™ 5 and PSA Density >15 | PracticeUpdate](https://d2ogjlfjkptkow.cloudfront.net/contentimage/31550.jpg)
Systematic Biopsy of the Prostate Can Be Omitted in Men With PI-RADS™ 5 and PSA Density >15 | PracticeUpdate
![Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80749-5/MediaObjects/41598_2020_80749_Fig1_HTML.png)
Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports
![JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies](https://pub.mdpi-res.com/jpm/jpm-10-00270/article_deploy/html/images/jpm-10-00270-ag.png?1607589479)
JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
![JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies](https://pub.mdpi-res.com/jpm/jpm-10-00270/article_deploy/html/images/jpm-10-00270-g001.png?1607589476)
JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
![Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer | BMC Urology | Full Text Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer | BMC Urology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12894-021-00928-y/MediaObjects/12894_2021_928_Fig1_HTML.png)
Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer | BMC Urology | Full Text
![Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-10859-9/MediaObjects/41598_2022_10859_Fig1_HTML.png)
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports
![Decision tree for managing PI-RADS 3 lesions in African American men... | Download Scientific Diagram Decision tree for managing PI-RADS 3 lesions in African American men... | Download Scientific Diagram](https://www.researchgate.net/publication/358479485/figure/fig1/AS:1134089595817992@1647399438637/Decision-tree-for-managing-PI-RADS-3-lesions-in-African-American-men-presenting-for.png)
Decision tree for managing PI-RADS 3 lesions in African American men... | Download Scientific Diagram
![PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract](https://www.urotoday.com/images/PIRADS-3_figure_3.png)
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
![PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract](https://www.urotoday.com/images/pirads-3_graphical_abstract.png)
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
![PI-RADS 3 lesions: a critical review and discussion of how to improve management | Abdominal Radiology PI-RADS 3 lesions: a critical review and discussion of how to improve management | Abdominal Radiology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00261-023-03929-7/MediaObjects/261_2023_3929_Figa_HTML.png)
PI-RADS 3 lesions: a critical review and discussion of how to improve management | Abdominal Radiology
![PI-RADS III (prostate cancer). a Axial T2-WI shows TZ heterogeneous... | Download Scientific Diagram PI-RADS III (prostate cancer). a Axial T2-WI shows TZ heterogeneous... | Download Scientific Diagram](https://www.researchgate.net/publication/348240795/figure/fig2/AS:982331863080969@1611217575943/PI-RADS-III-prostate-cancer-a-Axial-T2-WI-shows-TZ-heterogeneous-signal-intensity-with.png)
PI-RADS III (prostate cancer). a Axial T2-WI shows TZ heterogeneous... | Download Scientific Diagram
![Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology](https://www.auajournals.org/cms/asset/67d3528f-246f-4415-bdec-56c600a97803/abs-fig.jpg)
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
![Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - ScienceDirect Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283819308231-gr4.jpg)